To evaluate the activity of GlycACE2, we analyzed Ang 1–9, Ang 1–7, MasR, and NAFT in T2DM and non-T2DMventricular specimens (Fig. 6). The gene discussed is MAS1L; the disease is type 2 diabetes mellitus.